CC - The Chemours Company
NEXT EARNINGS:
May 5, 2026
EPS Est: $0.20
|
Rev Est: $1.4B
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$18.86
DETAILS
HIGH:
$23.00
LOW:
$17.00
MEDIAN:
$18.00
CONSENSUS:
$18.86
UPSIDE:
2.44%
Market Cap:
2.76B
Volume:
2,793,967
Avg Volume:
2,772,806
52 Week Range:
9.13-21.85
Sector:
Basic Materials
Industry:
Chemicals - Specialty
Beta:
1.64
Last Dividend:
$0.51
Exchange:
NYSE
Country:
US
Employees:
6,000
IPO Date:
2015-06-19
EPS (TTM):
-2.57
P/E Ratio:
-4.59
Revenue (TTM):
5.81B
Total Assets:
7.38B
Total Debt:
4.52B
Cash & Equiv:
672.00M
Rev Growth (5Y):
3.2%
EPS Growth (5Y):
-18.2%
FCF Growth (5Y):
-37.6%
ROCE:
-0.1%
Debt/Equity:
18.09
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-19 | $0.05 | $0.14 | -63.4% | $1.3B | $1.4B | -6.0% |
| 2025-11-06 | $0.20 | $0.24 | -16.7% | $1.5B | $1.3B | +12.5% |
| 2025-08-05 | $0.58 | $0.46 | +26.1% | $1.6B | $1.5B | +4.7% |
| 2025-05-06 | $0.13 | $0.19 | -31.6% | $1.4B | $1.4B | +1.2% |
| 2025-02-18 | $0.11 | $0.10 | +10.0% | $1.4B | $1.4B | +0.8% |
| 2024-11-04 | $0.40 | $0.32 | +25.0% | $1.5B | $1.4B | +11.0% |
| 2024-08-01 | $0.38 | $0.57 | -33.3% | $1.5B | $1.5B | +0.5% |
| 2024-04-30 | $0.32 | $0.18 | +77.8% | $1.4B | $1.4B | 0.0% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.81B | 5.78B | 6.08B | 6.83B | 6.34B | 4.97B | 5.53B | 6.64B | 6.18B | 5.40B | 5.72B | 6.43B |
| Net Income | (386.00M) | 86.00M | (238.00M) | 578.00M | 608.00M | 219.00M | (52.00M) | 995.00M | 746.00M | 7.00M | (90.00M) | 400.00M |
| EPS | -2.57 | 0.58 | -1.60 | 3.72 | 3.69 | 1.33 | -0.32 | 5.62 | 4.04 | 0.04 | -0.50 | 2.21 |
| Total Assets | 7.38B | 7.51B | 8.25B | 7.64B | 7.55B | 7.08B | 7.26B | 7.36B | 7.29B | 6.06B | 6.30B | 5.98B |
| Total Debt | 4.52B | 4.36B | 4.30B | 3.88B | 3.99B | 4.28B | 4.47B | 3.97B | 4.11B | 3.54B | 3.95B | 0 |
| Cash & Equivalents | 672.00M | 713.00M | 1.20B | 1.10B | 1.45B | 1.10B | 943.00M | 1.20B | 1.56B | 902.00M | 366.00M | 0 |
| Operating Cash Flow | 264.00M | (633.00M) | 556.00M | 755.00M | 814.00M | 807.00M | 650.00M | 1.14B | 639.00M | 594.00M | 182.00M | 505.00M |
| Free Cash Flow | 51.00M | (993.00M) | 186.00M | 448.00M | 537.00M | 540.00M | 169.00M | 642.00M | 228.00M | 256.00M | (337.00M) | (99.00M) |
| FCF per Share | 0.34 | -6.64 | 1.25 | 2.88 | 3.26 | 3.28 | 1.03 | 3.63 | 1.23 | 1.41 | -1.87 | -0.55 |
| Book Value | 250.00M | 604.00M | 737.00M | 1.11B | 1.08B | 813.00M | 689.00M | 1.01B | 860.00M | 100.00M | 126.00M | 3.67B |
| Cash & ST Investments | 672.00M | 713.00M | 1.20B | 1.10B | 1.45B | 1.10B | 943.00M | 1.20B | 1.56B | 902.00M | 366.00M | 0 |
| ROC Equity | -1.54 | 0.14 | -0.32 | 0.52 | 0.56 | 0.27 | -0.08 | 0.98 | 0.87 | 0.07 | -0.71 | 0.11 |